Pembrolizumab shows limited efficacy for metastatic uveal melanoma

• Posted on: Jun 25 2019
• By: Saratoga Opthalmology
• Leave a response

This prospective study investigated the efficacy and safety of pembrolizumab as a first-line therapy for metastatic uveal melanoma.
Source: AAO

Posted in: Uncategorized